Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04756154 · ClinicalTrials.gov registry record · Phase 3
Efficacy Study of Patient Preoperative Preps In-vivo
A Phase 3 study, sponsored by Solventum US.
- Completed
- Registry status
- Phase 3
- Development phase
- 154
- Enrollment target
NCT04756154 is a Phase 3 study that has completed, run by Solventum US. The registered enrollment target is 154 participants.
The verdict
NCT04756154, a Phase 3 study, has completed, sponsored by Solventum US.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 154 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the antimicrobial efficacy of an investigational CHG/IPA prep on skin flora of the inguinal regions of human subjects.
Interventions
- DRUG Normal saline
- DRUG CHG/IPA Surgical skin preparation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2020-07-06 |
| Est. Completion | 2021-04-28 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04756154
The ClinicalTrials.gov registry entry for NCT04756154 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 154 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Solventum US, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Normal saline is the first listed.
NCT04756154 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04756154 about?
NCT04756154 is a clinical study titled "Efficacy Study of Patient Preoperative Preps In-vivo". The purpose of this study is to determine the antimicrobial efficacy of an investigational CHG/IPA prep on skin flora of the inguinal regions of human subjects.
What is the current status of trial NCT04756154?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 154 participants. The study started on 2020-07-06. Estimated completion is 2021-04-28.
What interventions are being tested in trial NCT04756154?
The interventions under investigation include: Normal saline (DRUG), CHG/IPA Surgical skin preparation (DRUG).
Who is sponsoring clinical trial NCT04756154?
This trial is sponsored by Solventum US, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.